Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 6, 2007
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen Inc
|
0
|
$5.59 | -$20,403.61 |
—
| 124.9K |
Jun 7 - Jun 4
| |||||||
Immunogen Inc
| -23.50K |
$5.96 | -$139,966.00 | -15.84% | 124.9K |
Apr 13
| |||||||
Immunogen Inc
| -167.86K |
$5.65 | -$947,792.08 | -53.08% | 148.4K |
Apr 13
| |||||||
Immunogen Inc
|
0
|
$2.80 | -$97,030.36 |
—
| 124.9K |
Mar 22
| |||||||
Immunogen Inc
| 191.36K |
$2.38 | $454,677.15 | +153.21% | 316.26K |
Mar 27
| |||||||
Immunogen Inc
|
0
|
$4.11 | -$53,550.99 |
—
| 124.9K |
Mar 26
| |||||||
Immunogen Inc
|
0
|
$3.55 | -$643,985.19 |
—
| 124.9K |
Mar 23
| |||||||
Immunogen Inc
| 191.36K |
$2.38 | $454,677.15 | +153.21% | 316.26K |
Mar 27
| |||||||
Immunogen Inc
|
0
|
$4.11 | -$53,550.99 |
—
| 124.9K |
Mar 26
| |||||||
Immunogen Inc
|
0
|
$3.55 | -$643,985.19 |
—
| 124.9K |
Mar 23
| |||||||
Immunogen Inc
| 42.94K |
$3.64 | $102,948.36 | +34.38% | 124.9K |
Mar 22
| |||||||
Immunogen Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Immunogen Inc
| 25K |
$3.51 | -$37,980.00 | +25.03% | 124.9K |
Mar 6
| |||||||
Immunogen Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Immunogen Inc
| 14.19K |
$3.59 | -$90,352.48 | +16.55% | 99.9K |
Mar 9 - Mar 10
| |||||||
Immunogen Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Immunogen Inc
| 2.65K |
$6.13 | -$1,167.50 | +3.19% | 85.71K |
Jun 7
| |||||||
Immunogen Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |